RecruitingNCT07051967

Post-intensive Care Syndromes in Pregnant Patients With Respiratory Failure and COVID-19 Compared to Non-pregnant Patients With Respiratory Failure and COVID-19

Sponsor

Charite University, Berlin, Germany

Enrollment

40 participants

Start Date

Sep 22, 2025

Study Type

OBSERVATIONAL

Conditions

COVID-19 Pregnancy Related Acute Respiratory Distress Syndrome Due to COVID-19

Summary

The aim of this study is to characterize patients in the Post-Intensive-Care-Syndrome (PICS) outpatient clinic based on routine data and to evaluate their treatment outcome over the course of their treatment. For this purpose, data sets from approx. 40 patients who were treated in the intensive care unit subsequently evaluated in the PICS outpatient clinic between March 27, 2020, and May 6, 2024, will be analyzed.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with acute respiratory distress syndrome due to covid-19, covid-19, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07051967

Related Trials

Effects of Systematic Cervical Exam Training on Labor and Delivery Care

NCT044217681 location

Serological and PCR Testing for COVID-19

NCT044040621 location

Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

NCT056249312 locations

Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection

NCT052421591 location

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

NCT076551801 location